Janssen Labs: Meet with…the Office of Translational Research at NINDS/NIH
Tue, March 18, 11:00am – 3:30pm
Janssen Research & Development LLC; 3210 Merryfield Row, San Diego, CA 92121
Are you working on a technology with neurological applications? Are you seeking funding from the NIH? Then here is your chance to meet with representatives from the Office of Translational Research (OTR) at the National Institute of Neurological Disorders and Stroke (NINDS) for a one-on-one discussion of potential options.
On March 18, hear from Dr. Rajesh Ranganathan and Dr. Amir Tamiz on potential opportunities for licensing and/or partnership on current projects in their portfolio and non-dilutive funding opportunities. The OTR provides critical path funding (approximately $100M annually) and research resources for biotechnology companies and university researchers to advance early-stage neurological technologies, devices, and therapeutic programs to industry adoption (i.e., investor funding and corporate partnerships). Dr. Rajesh Ranganathan and Dr. Amir Tamiz will also discuss tips on preparing a competitive application, proper stage of development, and other factors that their institute is looking for when reviewing applications.
Following the presentation and Q&A, don't miss this opportunity to introduce yourself to the OTR at NINDS/NIH during the networking lunch. And finally, for those companies who have applied online and are approved, one-on-one meetings with Dr. Rajesh Ranganathan and/or Dr. Amir Tamiz will provide a forum to further discuss your company with them.
Don't miss the opportunity to meet one-on-one with the Office of Translational Research at NINDS/NIH!